FCAG
BIO icon

First Capital Advisors Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Capital Advisors Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-170
Closed -$43K – 236
2018
Q1 		$43K Buy
+170
New +$43.3K 0.02% 291

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Capital Advisors Group's BIO Position: Q2 2018 in Review

First Capital Advisors Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2018, closing a stake of 170 shares — an estimated $43K sold.

First Capital Advisors Group first reported a position in BIO in Q1 2018 and held it in 1 quarter. The position peaked at $43K in Q1 2018. 326 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

  • First Capital Advisors Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2018 after selling out during the quarter.
  • First Capital Advisors Group sold 170 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $43K.
  • First Capital Advisors Group first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 1 quarter.
  • First Capital Advisors Group's Bio-Rad Laboratories Class A position peaked at $43K in Q1 2018.
  • 326 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on First Capital Advisors Group's 13F filing for Q2 2018, filed 30 Jul 2018.